Combining gene expression profiling and machine learning to diagnose B-cell non-Hodgkin lymphoma
Source check: Source checked. Not independent scientific confirmation.
Finding: The primary paper uses a random-forest classifier on targeted gene-expression profiling to classify B-cell non-Hodgkin lymphoma subtypes and reports concordance against expert pathology and assay references. This is a specific hematopathology diagnostic result; the authors frame it as a complement to pathology. Publisher/author-hosted full text, Methods and Results: RT-MLPSeq 137-marker assay, 510 biopsies and seven subtype classes; validation against expert pathology and NanoString/immunostain references.
Technology: Publisher/author-hosted full text, Methods and Results: RT-MLPSeq 137-marker assay, 510 biopsies and seven subtype classes; validation against expert pathology and NanoString/immunostain references.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Publisher/author-hosted full text, Methods and Results: RT-MLPSeq 137-marker assay, 510 biopsies and seven subtype classes; validation against expert pathology and NanoString/immunostain references.
- Test and result
- Publisher/author-hosted full text, Methods and Results: RT-MLPSeq 137-marker assay, 510 biopsies and seven subtype classes; validation against expert pathology and NanoString/immunostain references.
- Limitation / still unknown
- Publisher/author-hosted full text, Methods and Results: RT-MLPSeq 137-marker assay, 510 biopsies and seven subtype classes; validation against expert pathology and NanoString/immunostain references. The source does not establish benefits beyond the reported evaluation.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.nature.com/articles/s41408-020-0322-5.pdf
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: other. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.